Dmitry Balyasny’s ArriVent BioPharma AVBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.06M Buy
+200,000
New +$6.13M 0.01% 1335

Other funds holding AVBP

Dmitry Balyasny's AVBP Position: Q3 2026 in Review

Dmitry Balyasny increased its ArriVent BioPharma (AVBP) stake by 27% in Q3 2026, buying an estimated $3.31M and bringing the position to 503,383 shares worth $15.2M. The position accounts for 0.02% of the portfolio, ranked #889.

Dmitry Balyasny first reported a position in AVBP in Q2 2025 and has held it in 5 quarters since. 153 funds tracked by Wall St. Rank hold AVBP as of Q3 2026.

  • Dmitry Balyasny held 503,383 shares of ArriVent BioPharma worth $15.2M as of Q3 2026.
  • Dmitry Balyasny bought 107,936 ArriVent BioPharma shares in Q3 2026, an estimated $3.31M.
  • ArriVent BioPharma made up 0.02% of Dmitry Balyasny's portfolio in Q3 2026, its #889 holding.
  • Dmitry Balyasny first reported a position in ArriVent BioPharma in Q2 2025 and has held it in 5 quarters since.
  • 153 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q3 2026.

Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.